Topic: How To Invest

Q: Pat: Zimmer Biomet looks like an interesting healthcare play. What do you and your team think about the stock? Thanks.

Article Excerpt

A: Zimmer Biomet Holdings Inc., $162.32, symbol ZBH on New York (Shares outstanding: 208.5 million; Market cap: $34.1 billion; www.zimmerbiomet.com), manufactures orthopedic reconstructive implants and surgical equipment for orthopedic surgeries. Zimmer has the largest market share for reconstructive implants in the U.S. On February 5, 2021, the company announced that it will spin off its Spine and Dental businesses into an independent, yet-to-be-named publicly traded company. The move will let Zimmer Biomet focus on its Hips and Knees segment, which accounted for 59% of its 2020 revenue of $7.0 billion. Current Zimmer Biomet CEO Bryan Hanson will stay in charge of the remaining business. A search is underway for a CEO to head the spinoff. The company intends to complete the tax-free split by the middle of 2022. Zimmer’s revenue rose 3.9%, from $7.68 billion in 2016 to $7.98 billion in 2019. Sales then fell 12.0% to $7.02 billion in 2020, as COVID-19 hurt demand for elective surgeries and the company’s products. Excluding one-time…